Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

ChromaDex Appoints Scripps Research Professor of Molecular Medicine, Brunie H. Felding, PhD, to the Scientific Advisory Board

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  ChromaDex Inc.

RedHill Biopharma Reports Second Quarter 2019 Financial Results and Operational Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  RedHill Biopharma Ltd.

EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 37th Annual Scientific Meeting of the American Society of Retina Specialists

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  EyePoint Pharmaceuticals, Inc.

AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Applied Genetic Technologies Corp. (AGTC)

Axogen, Inc. to Report Second Quarter 2019 Financial Results and Host Conference Call on August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  AxoGen, Inc.

resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  resTORbio, Inc.

BioCryst to Report Second Quarter 2019 Financial Results on August 6

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  BioCryst Pharmaceuticals, Inc.

Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Cytokinetics, Inc.

Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum Depression

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Marinus Pharmaceuticals, Inc.

Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence Study

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Myovant Sciences, Inc.

Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Idera Pharmaceuticals Inc.

VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Vivus, Inc.

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Aptose Biosciences Inc.

Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Neuronetics, Inc.

Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Opiant Pharmaceuticals, Inc.

Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Syapse, Inc.

Vericel to Report Second-Quarter 2019 Financial Results on August 6, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Vericel Corporation

Reflect Scientific Letter from the CEO

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019

Kintai Therapeutics Announces the Appointment of Mary Szela, Industry Veteran with Over 30 Years of Executive Experience, to its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Kintai Therapeutics

Alimera Sciences Announces Multiple Papers “On Demand” at the 2019 American Society of Retina Specialists Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Alimera Sciences, Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑